0

524764

NUTRA

img img img img
No Data Available

NUTRAPLUS INDIA LTD Share Price Update

As of the latest trading session, NUTRAPLUS INDIA LTD share price is currently at ₹2.1, which is up by ₹0.00 from its previous closing. Today, the stock has fluctuated between ₹1.90 and ₹2.10. Over the past year, NUTRAPLUS INDIA LTD has achieved a return of -60.67%. In the last month alone, the return has been 9.94%.

Investment Returns

Over 1 Month [-]% Over 3 Months 0.00% Over 6 Months [-]% Over 1 Year [-]%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

NUTRAPLUS INDIA LTD fundamentals


  • Market cap (Cr)

    [-]

  • P/E Ratio (TTM)

    [-]

  • Beta

    [-]

  • Book Value / share

    [-]

  • Return on equity

    [-]%

  • EPS (TTM)

    [-]

  • Dividend yield

    [-]%

  • Net profit/quarter (Cr)

    [-]

info icon alternate text
  • Market cap (Cr)

    0.0

  • P/E Ratio (TTM)

    0.0

  • Beta

    0.0

  • Book Value / share

    0.0

  • Return on equity

    0.0%

  • EPS (TTM)

    0.0

  • Dividend yield

    [-]%

  • Net profit/quarter (Cr)

    0.0

info icon alternate text

NUTRAPLUS INDIA LTD Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Particulars DEC 2025 (Values in Cr)
Revenue 0.00
Operating Expense 0.02
Net Profit -0.02
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) -0.01
EBITDA -0.02
Effective Tax Rate (%) 0.00
Particulars SEP 2025 (Values in Cr)
Revenue 0.00
Operating Expense 0.46
Net Profit -0.36
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) -0.11
EBITDA -0.36
Effective Tax Rate (%) 0.00
Particulars JUN 2025 (Values in Cr)
Revenue 0.00
Operating Expense 0.01
Net Profit -0.01
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) 0.00
EBITDA -0.01
Effective Tax Rate (%) 0.00
Particulars MAR 2025 (Values in Cr)
Revenue 0.00
Operating Expense 0.03
Net Profit -0.02
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) -0.01
EBITDA -0.03
Effective Tax Rate (%) 0.00
Particulars DEC 2024 (Values in Cr)
Revenue 0.00
Operating Expense 0.02
Net Profit -0.02
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) -0.01
EBITDA -0.02
Effective Tax Rate (%) 0.00
Particulars MAR 2025 (Values in Cr)
Revenue 0.00
Operating Expense 0.05
Net Profit -0.05
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) -0.01
EBITDA -0.05
Effective Tax Rate (%) 0.00
Particulars MAR 2024 (Values in Cr)
Revenue 0.00
Operating Expense 0.06
Net Profit -0.06
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) -0.02
EBITDA -0.06
Effective Tax Rate (%) 0.00
Particulars MAR 2023 (Values in Cr)
Revenue 0.00
Operating Expense 0.16
Net Profit -0.16
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) -0.05
EBITDA -0.13
Effective Tax Rate (%) 0.00
Particulars MAR 2022 (Values in Cr)
Revenue 0.10
Operating Expense 3.75
Net Profit -3.03
Net Profit Margin (%) -3029.99
Earnings Per Share (EPS) -0.89
EBITDA -3.03
Effective Tax Rate (%) 0.00
Particulars MAR 2021 (Values in Cr)
Revenue 0.02
Operating Expense 1.17
Net Profit -23.66
Net Profit Margin (%) -118300.00
Earnings Per Share (EPS) -7.19
EBITDA -18.42
Effective Tax Rate (%) 4.50
Particulars MAR 2015 (Values in Cr)
Book Value / Share 37.40
ROE % -2.73
ROCE % 2.87
Total Debt to Total Equity 1.07
EBITDA Margin 4.72
Particulars MAR 2014 (Values in Cr)
Book Value / Share 34.35
ROE % 15.46
ROCE % 16.67
Total Debt to Total Equity 1.56
EBITDA Margin 15.04
Particulars MAR 2012 (Values in Cr)
Book Value / Share 24.60
ROE % 23.06
ROCE % 20.82
Total Debt to Total Equity 1.16
EBITDA Margin 13.36
Particulars MAR 2025 (Values in Cr)
Book Value / Share -3.14
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.00
EBITDA Margin 0.00
Particulars MAR 2024 (Values in Cr)
Book Value / Share -3.11
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.00
EBITDA Margin 0.00
Particulars MAR 2023 (Values in Cr)
Book Value / Share -1.54
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.00
EBITDA Margin 0.00
Particulars MAR 2022 (Values in Cr)
Book Value / Share -1.49
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.00
EBITDA Margin -3030.00
Particulars MAR 2021 (Values in Cr)
Book Value / Share -0.60
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 3.97
EBITDA Margin -1350.00
Particulars MAR 2015 (Values in Cr)
Cash & Short Term Investments 11.42
Total Assets 114.06
Total Liabilities 114.06
Total Equity 47.17
Share Outstanding 1
Price to Book Ratio 3.06
Return on Assets (%) -3.55
Return on Capital (%) -4.9
Particulars MAR 2014 (Values in Cr)
Cash & Short Term Investments 1.48
Total Assets 75.23
Total Liabilities 75.23
Total Equity 20.24
Share Outstanding 0
Price to Book Ratio 0.38
Return on Assets (%) 4.16
Return on Capital (%) 6.39
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 0.06
Total Assets 5.16
Total Liabilities 5.16
Total Equity -5.35
Share Outstanding 3
Price to Book Ratio 0.00
Return on Assets (%) -0.97
Return on Capital (%) 1.41
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 0.06
Total Assets 5.25
Total Liabilities 5.25
Total Equity -5.30
Share Outstanding 3
Price to Book Ratio 0.00
Return on Assets (%) -1.17
Return on Capital (%) 1.75
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.05
Total Assets 5.25
Total Liabilities 5.25
Total Equity -5.23
Share Outstanding 3
Price to Book Ratio 0.00
Return on Assets (%) -2.99
Return on Capital (%) 4.52
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 0.06
Total Assets 5.39
Total Liabilities 5.39
Total Equity -5.08
Share Outstanding 3
Price to Book Ratio 0.00
Return on Assets (%) -56.14
Return on Capital (%) 91.04
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.09
Total Assets 9.47
Total Liabilities 9.47
Total Equity -2.04
Share Outstanding 3
Price to Book Ratio -4.68
Return on Assets (%) -258.62
Return on Capital (%) 8218.74
Particulars MAR 2015 (Values in Cr)
Net Income -2.51
Cash from Operations -16.48
Cash from Investing -5.10
Cash from Financing 31.52
Net change in Cash 9.94
Free Cash Flow 4.15
Particulars MAR 2014 (Values in Cr)
Net Income 5.10
Cash from Operations 2.68
Cash from Investing -10.82
Cash from Financing 6.84
Net change in Cash 0.00
Free Cash Flow 13.54
Particulars MAR 2025 (Values in Cr)
Net Income -0.05
Cash from Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00
Net change in Cash 0.00
Free Cash Flow 0.00
Particulars MAR 2024 (Values in Cr)
Net Income -0.06
Cash from Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.02
Net change in Cash 0.01
Free Cash Flow 0.00
Particulars MAR 2023 (Values in Cr)
Net Income -0.15
Cash from Operations 0.01
Cash from Investing 0.00
Cash from Financing -0.02
Net change in Cash -0.01
Free Cash Flow 0.01
Particulars MAR 2022 (Values in Cr)
Net Income -3.03
Cash from Operations -0.15
Cash from Investing 0.11
Cash from Financing 0.00
Net change in Cash -0.03
Free Cash Flow -0.15
Particulars MAR 2021 (Values in Cr)
Net Income -18.86
Cash from Operations -14.25
Cash from Investing 93.77
Cash from Financing -80.25
Net change in Cash -0.73
Free Cash Flow -14.25
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AMBALAL SARABHAI ENTERPRISES L 28.66 12.41 1.48 219.63 23.12 41.45
BLISS GVS PHARMA LTD. 261.00 24.95 2.43 2761.09 105.05 265.00
CIPLA LTD 1211.30 20.58 2.97 97846.71 1165.55 1672.20
FERMENTA BIOTECH LIMITED 325.80 10.84 2.45 958.86 252.15 399.00
GLAXOSMITHKLINE PHARMA LT 2409.85 40.59 23.90 40824.31 2218.00 3515.95
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AMBALAL SARABHAI ENTERPRISES L 28.66 27.56 3.99 219.63 23.12 41.45
AMRUTANJAN HEALTH CARE LTD. 525.20 26.26 4.43 1518.39 490.00 789.95
ASTRAZENECA PHARMA INDIA LTD. 8718.05 104.77 27.27 21795.13 7630.00 10653.05
BLISS GVS PHARMA LTD. 261.00 35.56 2.50 2761.09 105.05 265.00

NUTRAPLUS INDIA LTD shareholding pattern

Holding

59.72%
40.06%
0.2%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

NUTRAPLUS INDIA LTD Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
2.10 5.00 redarrow
red-green-graph indicator
0 Bearish
0 Bullish
  • 5 Days 0.00
  • 26 Days 0.00
  • 10 Days 0.00
  • 50 Days 0.00
  • 12 Days 0.00
  • 100 Days 0.00
  • 20 Days 0.00
  • 200 Days 0.00
0.0 PIVOT

First Support

0.0

First Resistance

0.0

Second Support

0.0

Second Resistance

0.0

Third Support

0.0

Third Resistance

0.0

RSI

0.0

ADX

0.0

MACD

0.0

Williams % R

0.0

Commodity Channel Index (CCI)

0.0

Date

[-]

Week

0.0

Same Day

0.0

Month

0.0

1 Year

0.0

3 Year

0.0

Over 1 Month

9.94%

down

Over 1 Year

-60.67%

down

Over 3 Months

0.00%

down

Over 3 Years

-52.30%

down

Over 6 Months

-18.60%

down

Over 5 Years

-40.89%

down

NUTRAPLUS INDIA LTD Corporate Actions

Dividend date Dividend amount Dividend type Record date Instrument type
06 Sep 2016 0.5 Final 08 Sep 2016 Equity shares
Ex-Date Ex-Bonus Ratio
20 Jan 2017 19 Jan 2017 1:10
Ex-Date Old FV NEW FV Record Date
27 Feb 2017 10.0 5.0 28 Feb 2017

Top Gainers

NUTRAPLUS INDIA LTD Share Price

Nutraplus Products (India) Limited was originally incorporated as a private limited company on 6 Feb.'90. It was subsequently converted into a public limited company with effect from 13 Jun.'92.

The company implemented a project for the manufacture of veterinary bulk drugs namely dimentridazole (DMZ) and dinitolmide (DOT) at Tarapur, Maharashtra. Initially, the company set up manufacturing facilities for the manufacture of methyl nitro imidazole, an intermediate of DMZ, with an installed capacity of 240 tpa, at a cost of Rs 123.66 lac, for which was sanctioned a term loan of Rs 60 lac from the Maharashtra State Financial Corporation (MSFC).

The company has set-up new product Roxarsone from Jan'96 and also set up production of Dinitolmide. During 2001-02 the company set up a production of newly developed Bulk Drugs Metformin HCL. It is also planning to foray in the manufacture of life saving drugs.

Parent organization Indian Private
NSE symbol [-]
Founded 1990
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Nutraplus India Ltd?

Answer Field

Nutraplus India Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 2.10 as on Dec 13 2021 12:00 AM.

What is the Market Cap of Nutraplus India Ltd Share?

Answer Field

The market cap of Nutraplus India Ltd for NSE ₹ 0.00 & for BSE ₹ 0.00 as on Dec 13 2021 12:00 AM.

What is the 52 Week High and Low of Nutraplus India Ltd?

Answer Field

The 52 Week High and Low of Nutraplus India Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 2.10 and ₹ 0.00.

What is 1 year return for Nutraplus India Ltd?

Answer Field

The 1 year returns on the stock has been -60.67%.

What is the P/E Ratio of Nutraplus India Ltd Share?

Answer Field

As on Dec 13 2021 12:00 AM the price-to-earnings (PE) ratio for Nutraplus India Ltd share is 0.0.

What is the PB ratio of Nutraplus India Ltd Share?

Answer Field

As on Dec 13 2021 12:00 AM, the price-to-book (PB) ratio for Nutraplus India Ltd share is 0.0.

How to Buy Nutraplus India Ltd Share?

Answer Field

You can trade in Nutraplus India Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Nutraplus India Ltd Share on Bajaj Broking App?

Answer Field

To buy Nutraplus India Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Nutraplus India Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image

Get Free Demat Account*

+91
close-img

Authorise with OTP

Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59